Literature DB >> 3449999

IgE responses in human gnathostomiasis.

M H Soesatyo1, W Rattanasiriwilai, P Suntharasamai, S Sirisinha.   

Abstract

Specific IgE antibody levels in the serum of patients with proven gnathostomiasis and in those with intermittent cutaneous migratory swellings were determined by the enzyme-linked immunosorbent assay (ELISA) using aqueous extracts of Gnathostoma spinigerum infective larvae as antigen. There was not only an elevation of specific IgE antibody levels but also a marked increase of total IgE in the serum of these patients. The mean levels of specific IgE antibody in both groups of patients were significantly higher than that of healthy controls (P less than 0.01). Only one of the 50 serum specimens tested had an ELISA reading that fell within the mean + 2 standard deviations of the control group, suggesting that the method would be useful with a high degree of reliability in confirming a clinical diagnosis of gnathostomiasis in humans. Compared with healthy controls, there was almost a 10-fold rise (P less than 0.01) in the total IgE in the serum of these patients, indicating that G. spinigerum infection potentiates IgE production similarly to many other nematode parasites.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3449999     DOI: 10.1016/0035-9203(87)90036-8

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  2 in total

1.  Characterization of the humoral immune response against Gnathostoma binucleatum in patients clinically diagnosed with gnathostomiasis.

Authors:  José Francisco Zambrano-Zaragoza; Ma de Jesús Durán-Avelar; Maud Messina-Robles; Norberto Vibanco-Pérez
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

2.  Study of specific IgG subclass antibodies for diagnosis of Gnathostoma spinigerum.

Authors:  Surang Nuchprayoon; Vivornpun Sanprasert; Montamas Suntravat; Kanyarat Kraivichian; Wilai Saksirisampant; Issarang Nuchprayoon
Journal:  Parasitol Res       Date:  2003-08-09       Impact factor: 2.289

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.